# The Microbiome in Blood Cancer and HLH

> **NCT06734624** · — · NOT_YET_RECRUITING · sponsor: **University of Nottingham** · enrollment: 750 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma (DLBCL)
- Follicular Lymphoma (FL)
- Haemophagocytic Lymphohistiocytosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06734624
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2039-12-31
- **Final completion:** 2044-12
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06734624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06734624, "The Microbiome in Blood Cancer and HLH". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06734624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*